Monday was the first day since November 2023 where retail investors flipped to selling.

The fund’s blockbuster public debut underscores how hungry retail investors are to get a piece of private companies.

The American beauty giant is in the midst of a turnaround plan that it says will cost up to $1.6 billion. Shares in each company…

Sports-related contracts have come to take a good chunk of prediction market volumes.

Wegovy HD was the first drug to be approved through the FDA’s new priority voucher system.

Wegovy HD was the first drug to be approved through the FDA’s new priority voucher system.

Patients taking the highest dose of retatrutide lost 16.8% of their body weight after 40 weeks, more than its current bestseller, tirzepatide.

Optics companies have rallied this year on expectations of higher demand for the components they make.

Its technology has been used on the battlefield in Ukraine, and the company’s IPO comes amid the ongoing conflict in Iran.

HSBC also cut its price target to $850 from $1,070. The stock is currently trading around $989.